summary
Introduced
07/13/2023
07/13/2023
In Committee
07/13/2023
07/13/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.
AI Summary
This bill establishes an Emerging Pathogen Preparedness Program within the Food and Drug Administration (FDA) to improve regulatory oversight of medical countermeasures for future pandemics. The program will facilitate the development, review, licensure, approval, and clearance of countermeasures and related products under the jurisdiction of the FDA's Center for Biologics Evaluation and Research. The program's activities may include advancing scientific research, enhancing surveillance programs, ensuring blood safety and availability, prioritizing the development of platform vaccine technologies, and other necessary or appropriate actions. The bill authorizes $60 million in appropriations for each of the fiscal years 2024 through 2028 to carry out these activities.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 07/13/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/senate-bill/2329/all-info |
| BillText | https://www.congress.gov/118/bills/s2329/BILLS-118s2329is.pdf |
Loading...